Understanding the cascade of molecular events leading to Rett syndrome
Characterizing the trajectory of molecular events leading to Rett syndrome opens new opportunities for novel therapeutic approaches.
Read MoreCharacterizing the trajectory of molecular events leading to Rett syndrome opens new opportunities for novel therapeutic approaches.
Read MoreNearly 25 years after the discovery that mutations in MECP2 gene cause Rett syndrome, the first gene therapy trial for this difficult-to-treat condition is underway.
Read MoreDBS results in a significant and long-lasting improvement to memory in Rett animal models strongly suggesting evaluating this approach to treat Rett patients.
Read MoreFrom the Labs celebrates National Postdoc Appreciation Week with a sample of the work conducted by Baylor postdocs.
Read MoreDr. Zoghbi is being recognized for two discoveries – ATAXIN1, the gene responsible for spinocerebellar ataxia 1, and MECP2, the gene responsible for Rett syndrome.
Read MoreResearchers have discovered that diminished memory recall in Rett syndrome mice can be restored by activating specific inhibitory cells in the hippocampus.
Read MoreEarly physical training triggers more dendritic arbors or cellular projections in hippocampal neurons (red), enhancing their functionality.
Read MoreIn a mouse model of Rett syndrome, early intensive training substantially delayed the appearance of symptoms and improved performance.
Read MoreDrs. Mary K. Estes, Bert O’Malley and Huda Zoghbi of Baylor College of Medicine were three of the 148 renowned academic inventors named fellows of
Read MoreSince being honored with the prestigious Breakthrough Prize in Life Sciences, Baylor College of Medicine’s Dr. Huda Zoghbi has been busy, but not just with
Read More